Skip to main content

Table 1 Baseline characteristics of patients with BC

From: A novel molecular subtypes and risk model based on inflammatory response-related lncrnas for bladder cancer

Covariates

Total

Train

Test

chi

P

Age

 <=65

160(39.41%)

83(40.69%)

77(38.12%)

0.280

0.597

 >65

246(60.59%)

121(59.31%)

125(61.88%)

  

Gender

 Female

107(26.35%)

62(30.39%)

45(22.28%)

3.444

0.063

 Male

299(73.65%)

142(69.61%)

157(77.72%)

  

Grade

 High

383(94.33%)

191(93.63%)

192(95.05%)

0.780

0.377

 Low

20(4.93%)

12(5.88%)

8(3.96%)

  

 unknow

3(0.74%)

1(0.49%)

2(0.99%)

  

Smoked

 NO

109(26.85%)

63(30.88%)

46(22.77%)

3.790

0.052

 YES

284(69.95%)

133(65.2%)

151(74.75%)

  

 unknow

13(3.2%)

8(3.92%)

5(2.48%)

  

Stage

 I-II

131(32.27%)

68(33.33%)

63(31.19%)

0.214

0.644

 III-IV

273(67.24%)

135(66.18%)

138(68.32%)

  

 unknow

2(0.49%)

1(0.49%)

1(0.5%)

  

T

 T0/X

2(0.49%)

0(0%)

2(0.99%)

2.683

0.221

 T1-2

121(29.8%)

66(32.35%)

55(27.23%)

  

 T3-4

251(61.82%)

123(60.29%)

128(63.37%)

  

 unknow

32(7.88%)

15(7.35%)

17(8.42%)

  

M

 M0/X

392(96.55%)

196(96.08%)

196(97.03%)

0.088

0.766

 M1

11(2.71%)

6(2.94%)

5(2.48%)

  

 unknow

3(0.74%)

2(0.98%)

1(0.5%)

  

N

 N0/X

272(67%)

140(68.63%)

132(65.35%)

0.507

0.477

 N1-3

128(31.53%)

61(29.9%)

67(33.17%)

  

 unknow

6(1.48%)

3(1.47%)

3(1.49%)

 Â